- Chronic Lymphocytic Leukemia Research
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- PI3K/AKT/mTOR signaling in cancer
- Lymphoma Diagnosis and Treatment
AbbVie (United States)
2023
Abstract Small molecule inhibitors of Bruton's tyrosine kinase (BTK) have been approved for the treatment multiple B-cell malignancies and are being evaluated autoimmune inflammatory diseases. Various BTK (BTKi) distinct potencies, selectivity profiles, binding modes within ATP-binding site. On basis latter feature, BTKis can be classified into those that occupy back-pocket, H3 pocket, hinge region only. Hypothesizing differing may differential impact on receptor (BCR) signaling pathway, we...
<div>Abstract<p>Small molecule inhibitors of Bruton's tyrosine kinase (BTK) have been approved for the treatment multiple B-cell malignancies and are being evaluated autoimmune inflammatory diseases. Various BTK (BTKi) distinct potencies, selectivity profiles, binding modes within ATP-binding site. On basis latter feature, BTKis can be classified into those that occupy back-pocket, H3 pocket, hinge region only. Hypothesizing differing may differential impact on receptor (BCR)...
<p>Supplemental Figure 2</p>
<p>Supplemental Figure 3</p>
<p>Supplemental methods</p>
<p>Back-pocket and H3 pocket binders but not hinge-only inhibit calcium flux in Ramos TMD8 cells</p>
<p>Supplemental Figure 4</p>
<div>Abstract<p>Small molecule inhibitors of Bruton's tyrosine kinase (BTK) have been approved for the treatment multiple B-cell malignancies and are being evaluated autoimmune inflammatory diseases. Various BTK (BTKi) distinct potencies, selectivity profiles, binding modes within ATP-binding site. On basis latter feature, BTKis can be classified into those that occupy back-pocket, H3 pocket, hinge region only. Hypothesizing differing may differential impact on receptor (BCR)...
<p>Back-pocket and H3 pocket binders but not hinge-only inhibit calcium flux in Ramos TMD8 cells</p>
<p>Supplemental Figure 3</p>
<p>Supplemental Figure 1</p>
<p>Supplemental methods</p>
<p>Supplemental Figure 4</p>
<p>Supplemental Figure 1</p>
<p>Supplemental Figure 2</p>